logo

Corporate News

Share

General Motors said it plans to increase vehicle production at its plants in North America from next week. The automaker noted that the restart of production at its component and assembly plants has gone smoothly. "Our comprehensive safety procedures are working well, and our suppliers have done...

Shares of Esports Entertainment Group, Inc. (GMBL) surged over 40 percent on Friday morning. GMBL is currently trading at $7.68, up $2.26 or 41.70%, on the Nasdaq. Shares of the Malta-based online sports gambling company has been gaining after it announced that it has formed a new subsidiary in New...

Novartis's gene-therapy arm AveXis will begin manufacturing a gene-based coronavirus vaccine this month. The vaccine being developed by scientists at Massachusetts Eye and Ear hospital, Massachusetts General and the University of Pennsylvania. As per a deal with Massachusetts researchers, AveXis will...

Shares of Canopy Growth Corp. (CGC, WEED.TO) are losing more than 18 percent or $3.94 in Friday's morning trade at $17.78 after the Canadian cannabis company's fourth-quarter results missed analysts' estimates. The stock has traded in a range of $9.00 to $44.17 in the past 52 weeks. Friday, Canopy...

Shares of Sonoma Pharmaceuticals Inc. (SNOA) are up over 200% in Friday's trading, following its partner MicroSafe Group winning regulatory approval for Nanocyn Disinfectant & Sanitizer for use against SARS-CoV-2 in Australia.

Shares of Phio Pharmaceuticals Corp. (PHIO) surged over 125% on Friday morning after the company announced positive data from studies showing strong antitumoral efficacy with several of its pipeline programs. PHIO is currently trading at $5.09, up $2.85 or 127.24%, on the Nasdaq. The Marlborough,...

Shares of Williams-Sonoma Inc. (WSM) are rising more than 10 percent or $7.61 in Friday's morning trade at $80.64, after touching a new 52-week high of $80.95 earlier as the omni-channel specialty retailer's first-quarter results trumped analysts' estimates. Thursday, Williams-Sonoma said its first-quarter...

Johnson & Johnson said that its Janssen Pharmaceutical Companies received a positive opinion from the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA for its investigational Ebola vaccine regimen for the prevention of the Ebola Virus Disease caused by the...

Costco Wholesale Corp. will resume its free in-store samples from mid-June, but with some changes. The warehouse chain had suspended offering free samples in its wholesale clubs from early March to prevent the spread of the coronavirus. Costco's free samples of food as well as non-food items are...

investing biotech 042420 29may20 Here's a quick look at some of today's ASCO presentations.

Arvinas, Inc. (ARVN) announced updated data from the dose escalation portion of the Phase 1/2 clinical trial of ARV-110 in men with metastatic castration-resistant prostate cancer. The company said the data show clinical activity, including both efficacy and AR degradation, in a heavily pretreated patient...

Adaptimmune Therapeutics plc (ADAP), in an update on its ADP-A2M4 Phase 1 trial, said that data demonstrated durability and responses in synovial sarcoma, supporting SPEARHEAD-1 as a potential registrational trial. The company also announced new responses in the SURPASS trial, confirming the potential...

AstraZeneca Plc (AZN.L, AZN) said Friday that results from the global Phase II Study 22 trial testing the company's tremelimumab added to IMFINZI (durvalumab) demonstrated promising clinical activity and tolerability in patients with advanced hepatocellular carcinoma or HCC. Tremelimumab is an anti-CTLA4...

fda recall apotex 052920 Apotex Corp. recalled all lots of type 2 diabetes medication Metformin hydrochloride in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.

AstraZeneca plc (AZN) announced Friday that detailed results from an updated analysis of the Phase III CASPIAN trial showed IMFINZI in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin, demonstrated a sustained, clinically meaningful overall survival (OS) benefit...

Follow RTT